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THE ROLE OF RETINOIC ACID IN THE SYNTHESIS OF 
RAPIDLY LABELED NUCLEAR RIBONUCLEIC ACID
CHAPTER I 
INTRODUCTION
Vitamin A, one of the earliest vitamins to be discovered, is an 
absolute nutritional requirement for life in almost all animal species.
On the other hand, there is apparently no nutritional nor metabolic re­
quirement of vitamin A or its derivatives by microorganisms, plants nor 
insects. This observation alone indicates that vitamin A possibly func­
tions in the specific regulation of the complex animal. However, vitamin 
A must be obtained from the diet rather than by synthesis in the animal 
body. The specificity of target organs, e.g., epithelial cells, as well 
as species specificity indicates a highly specialized role for as vitamin 
A as compared to the B vitamins which appear to function as precursors of 
coenzyme compounds essential to all life.
Dietary provitamins and vitamin A are sources of tissue deposits 
of retinol, retinyl esters, retinal and retinoic acid. Retinyl esters 
and retinol constitute a storage and transport system (1) which allows a 
continuous supply of the active form of the vitamin to whatever site is 
required. 11-Cis-retinal is the active form of vitamin A in vision, being 
the prosthetic group of the visual pigments (2). The role of vitamin A
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in vision has been reviewed (3). Retinoic acid and its esters were first 
obtained during attempts at the chemical synthesis of retinol (4). The 
finding that retinoic acid had relatively high biological activity in rat 
growth led to the speculation that retinoic acid was a metabolite of ret­
inol, and was a precursor of, or was itself, the systemically active form 
of vitamin A (b). Attempts to trap radioactivity in unlabeled retinoic 
acid after administration of ^^C-retinol have not been successful (6, 7). 
Failure to detect retinoic acid may be due to its rapid metabolism; also 
much of the retinal given to animals would be stored as retinyl esters 
and would, therefore, be protected from oxidation. Malathi et al. (s) 
reported that retinoic acid was 141% as active as retinyl acetate in a 
series of experiments to measure the changes in body weight in vitamin 
A-deficient rats given retinoic acid intraperitoneally. The formation 
of retinoic acid in vivo, essential for the normal biological action of 
retinol has not yet been proved. Experimental evidence is, however, com­
patible with the view that retinoic acid is a normal precursor of the 
active forms of vitamin A (9).
Although the role of vitamin A in vision is important, this is 
not its only function, since an animal can die from vitamin A deficiency 
but not necessarily from blindness. What is the role of vitamin A in 
metabolism? How does the vitamin act at the molecular level in the tis­
sue cells? Numerous attempts have been made to establish the nutritional 
role of vitamin A in the animal body. Although much effort and research 
have been extended in the field of the morphological changes caused by 
vitamin A deficiency such as epithelial keratinization, the cause of such 
morphological changes has not been established at the molecular level.
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At the present time, the biological mechanism of vitamin A action has not 
been established. However, the findings from the following studies on 
the role of vitamin A in nutrition may suggest that the site of action of 
vitamin A in the tissue cells is in the regulation of specific protein 
synthesis (lO). If this is true, this regulation may take place either 
at the transcription level, i.e., in RNA synthesis, or at the translation 
level, i.e., in protein synthesis.
1) Using ^^C-labeled acetate, lactate, glycerol and glucose it 
was found that the conversion of acetate, lactate and glycerol but not 
glucose to liver glycogen was blocked by vitamin A deficiency using pair- 
fed controls (ll, 12). Corticosterone completely reversed this block al­
though it did not cure the gross symptoms of vitamin A deficiency. On 
this basis it was proposed that the deficiency caused some adrenal change 
interfering with glucocorticoid production. A number of different sites 
of function of vitamin A has been proposed with regard to steroid hormones 
(ll, 13-17). Treatment of the vitamin A-deficient rat with corticoster­
one or cortisone did not alter the deficiency (ll) and even made it worse 
(is). This suggested that vitamin A deficiency resulted in a nutritional 
destruction of adrenal cortex function even though little change could be 
seen by analytical methods.
2) The possible nutritional role of vitamin A in the biosynthe­
sis of mucopolysaccharide (MPS) in the rat has been extensively examined. 
Vitamin A deficiency lowered the incorporation of ^^S-sulfate and ^^C- 
glucose into intestinal MPS (l9, 20, 2l). However, some workers have re­
ported no effect of vitamin A deficiency on this reaction (22, 23) and 
this has recently proved to be an inanition effect (24, 25).
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3) Vitamin A has been implicated with the functioning of those 
membranes involved with NADPH mixed function oxidation reactions (l3, 26, 
27). A 30 to 70^ reduction in liver microsomal codeine demethylase ac­
tivity was found which varied as a function of the deficiency (28). It 
was also found that the marked increase in the activity of the enzyme 
brought about by phénobarbital or codeine was inhibited by vitamin A de­
ficiency (29) and that the cure by vitamin A within 48 hours as measured 
by increased codeine demethylase activity was inhibited by actinomycin D 
(30). Again this has recently been shown to be an inanition effect (3l).
4) The early literature on the effect of vitamin A nutrition
on differentiation and structure of epithelial mucosal cells has been re­
viewed (32). It was reported that vitamin A completely suppressed kera­
tinization in cultured skin cells from 9 day old chick embryos (33). Vi­
tamin A also has been reported to inhibit squamous changes in skin can­
cers induced by chemical agents (34, 35). Palludan suggested that the 
effect of vitamin A on the testes is direct and not via hormone produc­
tion (36).
5) De Luca et have found that certain aminoacyl-t-RNA syn­
thetases of the intestinal mucosa are decreased by vitamin A deficiency 
(10). From this finding they concluded that protein synthesis by mem­
brane-bound but not by free polyribosomes of intestinal mucosa was de­
pressed under conditions of vitamin A deficiency and that vitamin A is 
therefore involved, directly or indirectly, in protein synthesis at the 
translation level. They also suggested that vitamin A has a regulatory 
role in specific protein synthesis.
6) Zachman has reported that retinol administration stimulated
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the in vivo incorporation of labeled uridine into total intestinal muco­
sal RNA of the vitamin A-deficient rat, but that it had no effect on the 
rate of incorporation of labeled uridine into liver or kidney RNA (37).
From the work described above, it appeared that a site to ex­
amine in searching for the role of vitamin A is in the regulation of syn­
thesis of specific protein and thus control of cell structure and differ­
entiation. Since specific proteins are molecules that confer specificity 
of function and/or morphology and since this regulation might most prob­
ably take place at the transcription level, i.e., in RNA synthesis, this 
was the site examined.
CHAPTER II 
MATERIALS AND METHODS 
Materials 
Animals
Weanling male albino rats of the Holtzman and Sprague-Dawley 
strains were maintained on vitamin A-normal or A-deficient diets as de­
scribed below (38). All animals were watered with distilled water.
Vitamin A deficiency usually developed 5 to 8 weeks after main­
taining the animals on the vitamin A-deficient diet. The body weights 
of the deficient rats averaged 30 to 50 grams less than the normal rats.
Diet Materials
The composition of the vitamin A normal diet is shown below.
The vitamin-free casein, sucrose, NRL salt mixture, choline chloride, L- 
cystine, Alphacel, dextrose, and vitamin D (Calciferol) were obtained 
from Nutritional Biochemicals Corporation, Cleveland, Ohio. Sigma Chem­
ical Company, St. Louis, Missouri, provided the remaining vitamins. The 
sucrose was purchased from Collin and Dietz, Wholesalers and the cotton­
seed oil came from a local manufacturer.
7
Diet Composition 
Ingredient per Kq diet
Vitamin-free casein (heated) 240.0 g
Sucrose 645.0 g
Salt mix 446 50.0 g
Heat-treated cotton seed oil 30.0 g
Choline citrate 3.0 g
Vitamin premix (described below) 10.0 g
Cysteine 2.0 g
Ascorbic acid 0.1 g
Alphacel 20.0 g
The composition of the vitamin premix was as follows:
Ingredient per 100 g
Thiamine-HCl 0.25 g
Riboflavin 0.25 g
Calcium panthothenate 0.80 g
Nicotinic acid 1.50 g
Pyridoxine-HCl 1.50 g
Biotin 0.01 g
Folic acid 0.05 g
Vitamin 8^2 (0.1% in mannitol) 0.20 g
Menadione 0.02 g
Alpha-tocopheryl succinate 6.0 g
Vitamin D (Calciferol) 0.04 g (2,000 I.U.)
Vitamin A palmitate 0.80 g (20,000 I.U.)
Dextrose 89.58 g
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For the vitamin A-deficient diet the vitamin A palmitate was eliminated 
from the vitamin premix and supplemented with dextrose to make 100 g 
vitamin premix.
Reagents
Potassium retinoate was prepared by dissolving a given amount 
of retinoic acid which was obtained from Hoffmann-La Roche & Company, 
Basle, Switzerland,in 0.2 N potassium hydroxide solution, adjusting to 
pH 7.5 with a 20^ potassium acetate solution that had been adjusted to 
pH 5.0 with glacial acetic acid. This solution was diluted with normal 
saline to make up the desired concentration.
Retinol obtained from Hoffmann-La Roche & Company was dissolved 
in absolute ethyl alcohol and diluted with deionized water to make a 50% 
ethanol solution. Tritium labeled retinoic acid (vitamin A -IC^ll-^Hg- 
acid) was obtained from Hoffmann-La Roche & Company. A solution contain­
ing 41.05 mg (= 14.46 mCi) in toluene was prepared having a specific ac­
tivity of 352 |j,Ci per mg.
Tritium labeled uridine (uridine-5-^H) was obtained from New 
England Nuclear Corporation, Boston, Massachusetts. Different lots con­
tained from 0.012 to 0.015 mg uridine per mCi. Labeled uridine was dis­
solved in sterile normal saline to an initial concentration of 100 pCi 
per 0.5 ml and diluted when required, with normal saline, to a final con­
centration of 5 or 10 jiCi per 0.5 ml for injection. This sterile normal 
saline contained 0.9 g of sodium chloride, U.S.P. in 100 ml and was ob­
tained from Cutter Laboratories, Berkeley, California.
Tritium labeled thymidine was obtained from New England Nuclear 
Corporation, Boston, Massachusetts. Five |iCi of thymidine-^H per 0.5 ml
9
per animal was used.
NCS-Reagent obtained from Nuclear-Chicago Corporation, Des 
Plaines, Illinois, was used as a solubilizer for tissue homogenate for 
liquid scintillation counting (39). The composition of the scintillation 
fluid used was as follows: PP0...10 g, POPOP...0.5 g. Naphthalene...80 g.
Xylene...143 ml, p-Dioxane...429 ml and Ethylene glycol monoethyl ether. 
...429 ml. The following chemicals were obtained from Packard Instrument 
Company, Downers Grove, Illinois: PPG (2,5-diphenyloxazole) and POPOP
(l,4-bis-[2-(4-methyl-5-phenyloxazolyl)]-benzene.
Sucrose used for sucrose density gradient centrifugation was ob­
tained from Mann Research Laboratories, New York, N. Y., and was free 
from ribonuclease.
Ribonucleic acid from Torula yeast. Grade VI, and deoxyribonuc- 
lei acid from calf thymus, sodium salt, highly polymerized, Type I, were 
also obtained from Sigma Chemical Company and were used to make standard 
RNA and DNA solutions. Ribonuclease-A from bovine pancreas, 5 x crystal­
lized, type 1-A, was obtained from Sigma Chemical Company, St. Louis.
Extraction buffer was made up as follows: 0.3% sodium deoxy-
cholate and 0.1% polyvinyl sulfate in 0.03 M phosphate buffer containing 
0.14 M sodium chloride, pH 6.8.
The following chemicals were obtained from Fisher Scientific 
Company, Philadelphia, Pennsylvania: sodium chloride, sodium acetate,
sodium hydroxide, potassium chloride, potassium acetate, potassium hy­
droxide, tri (hydroxymethyl) amino methane, potassium dihydrogen phos­
phate, dipotassium hydrogen phosphate, trichloroacetic acid, copper chlo­
ride, magnesium chloride, orcinol, xylene, sodium deoxycholate and lique-
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fied phenol which were all reagent or analytical grade.
Naphthalene was obtained from Eastman Kodak Company, Rochester,
New York.
Polyvinyl sulfate was obtained from K & K Laboratories, Inc.,
Plainview. New York.
P-dioxane, ethyl oxide, ethylene glycol monoethyl ether and iso­
amyl alcohol were obtained from Baker Chemical Company, Phillipsburg,
New Jersey.
Pure U.S.P. ethyl alcohol was obtained from U.S. Industrial 
Chemicals Co., New York, New York.
Instruments and Equipment 
Spectrophotometric measurements were made either using a Beckman 
DU-2 from Beckman Instruments Company, South Pasadena, California, or a 
Gilford Model 240 from Gilford Instrument Laboratories, Inc., Oberlin, 
Ohio. Centrifugations were carried out with an International Refrigerated 
Centrifuge, International Equipment Company, Boston, Massachusetts, a 
Sorvall Automatic Refrigerated centrifuge, RC 2-B, Ivan Sorvall, Inc., 
Norwalk, Connecticut and a Spinco Model L2-65 Ultracentrifuge, Beckman 
Instruments Company, Spinco Division, Palo Alto, California. The water 
bath used was Metabolyte Water-Bath Shaker with temperature control. Model 
G 77, New Brunswick Scientific Company, Inc., New Brunswick, New Jersey. 
Radioactivity was measured with a Mark I, Liquid Scintillation Counter, 
Nuclear-Chicago Corporation, Des Plaines, Illinois.
11
Methods
Total RNA Isolation 
Total RNA was isolated by a method modified from that of Lang 
and Sskeris (40). Individual rat liver (average weight of vitamin A-de­
ficient rat liver, 4 g) was homogenized in 20 ml of extraction buffer 
using a Potter-Elvehjem glass homogenizer. The homogenate was trans­
ferred to a flask containing 20 ml 80^ phenol and extracted for 30 min­
utes at 65°C with vigorous shaking. Twenty milliliters 0.9^ saline was 
added and the suspension centrifuged for 30 minutes at 15,000 rpm. The 
upper aqueous layer was saved. The interphase and lower phenol phase 
were treated with an additional 20 ml extraction buffer for 15 minutes 
at 65*C with vigorous shaking. Centrifugation was carried out as before 
and the two supernatants were combined and shaken with 20 ml 80^ phenol 
for 15 minutes at room temperature. After separating the aqueous phase 
from the phenol phase by centrifugation, the aqueous phase was washed at 
least three times with an equal volume of peroxide-free diethyl ether. 
Residual ether was removed by passing nitrogen gas through the solution. 
One drop of 10^ sodium chloride solution was added per 2 ml of the aque­
ous solution. The RNA was precipitated by adding two volumes of 90% 
ethyl alcohol and storing the solution in a freezer overnight.
The RNA obtained was purified as follows: The RNA was collected 
by centrifugation and dissolved in 0.01 M sodium acetate buffer, pH 5.1, 
containing 0.1 M sodium chloride, precipitated by addition of two volumes 
of ethyl alcohol and stored in a freezer for at least one hour. This pro­
cedure was repeated. The purified RNA precipitate was dissolved in 20 ml 
of the 0.01 M sodium acetate buffer, pH 5.1.
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Isolation of Liver Nuclei 
Nuclei were isolated using the method of Widnell and Tata (4l). 
Livers of two to four rats were pooled for each isolation. All proced­
ures were performed at 0° to 4*C. The tissue was rinsed once with ice- 
cold saline and minced with a pair of scissors in three volumes of 0.32 
M sucrose solution containing 3 mM magnesium chloride (one part liver, 
three parts medium). The minced liver was homogenized in a Potter- 
Elvehjem glass homogenizer. The homogenate was filtered through two 
layers of cheese cloth and the filtrate was diluted to 0.25 M with ice- 
cold deionized water. The sucrose solution was centrifuged at 2,000 rpm 
for 10 minutes. The supernatant was saved for the isolation of cyto­
plasmic RNA. The nuclear pellet thus obtained was purified as follows: 
it was suspended in 2.4 M sucrose solution containing 0.001 M magnesium 
chloride with the aid of a homogenizer and centrifuged in a Spinco No. 30 
rotor at 25,000 rpm for 60 minutes. In some experiments this purifica­
tion step was repeated.
Liver Nuclear RNA Isolation 
The isolated nuclei (approximately 0.1 g) were treated accord­
ing to the method of Lang and Sekeris (40) as follows: the nuclei ob­
tained were homogenized in a 20 ml extraction buffer; the homogenate was 
shaken with 10 ml 80% phenol for 15 minutes at 50°C and centrifuged at 
15,000 rpm for 30 minutes. For sedimentation in sucrose density grad­
ients, the aqueous supernatant obtained from the first centrifugation 
was combined with the second supernatant after extraction at 65°C. How­
ever, for other experiments the first supernatant was treated separately. 
A second supernatant was obtained by extracting the interphase and phenol
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phase with another 20 ml extraction buffer for 15 minutes at 65 C. The 
supernatant was treated exactly as in the total RNA isolation procedure 
described above. The nuclear RNA thus obtained is reported to be high 
in messenger activity (40).
RNA Isolation from the Small Intestine 
The small intestine was quickly removed from the body and washed
with cold saline, both inside and outside. The small intestine was 
stretched out on an iced glass plate in a cold room and laid open longi­
tudinally with a pair of scissors. The mucosal membranes were scraped 
off on the iced glass plate by means of a 25 x 75 mm micro slide and ho­
mogenized in a Potter-Elvehjem homogenizer.
RNA Isolation from Kidney 
Kidney was first roughly homogenized by means of a small size 
Waring Blender and then more thoroughly dispersed using a Potter-Elvehjem
glass homogenizer. After homogenization, the isolation steps were the
same as those described above for liver RNA.
DNA Isolation from Liver and Intestinal 
Mucosal Membranes
After the nuclei were isolated according to the method described
above (41), DNA was isolated using the "hot-salt" method of Niehaus and
Barnum (42) and purified and solubilized by the method of Chandler and
Neuhans (43) to count the radioactivity and to determine the amount of
DNA present in the solution. The nuclear pellet was dispersed in 10^
sodium chloride in 0.4 M Tris-HCl buffer, pH 7.8, incubated at 80°C for
30 minutes and centrifuged. The supernatant was treated by the addition
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of two volumes of 95% ethyl alcohol and centrifuged. The precipitate 
was treated with 0.1 N sodium hydroxide solution at 80 to 90°C for 30 
minutes to hydrolyze the RNA, cooled in an ice-bath. Trichloroacetic 
acid was added to make a 5% solution and centrifuged. The last step was 
repeated again. The precipitate was washed with absolute ethyl alcohol 
twice and then with ether. The DNA thus obtained was dissolved in 0.5 M 
perchloric acid solution and heated at 80°C for 30 minutes. One milli­
liter of this solution was used for the radioactivity determination and 
0.2 ml of the solution was used for the DNA assay.
Isolation of Microsomal RNA from Liver 
The microsomal pellet was obtained from the cytoplasmic portion 
after separating the nuclei, followed by centrifugation at 25,000 rpm for 
60 minutes in a Spinco No. 30 rotor of Model L Ultracentrifugation. The 
microsomal pellet was treated to obtain microsomal RNA in a manner similar 
to the liver nuclear RNA isolation described above.
Isolation of Transfer RNA from Liver 
Transfer RNA was isolated from the supernatant after removal of 
the microsomal pellet. Further the pH of this supernatant was adjusted 
to 5.0 with 0.01 M acetic acid solution, and allowed to stand for a few 
minutes to settle the precipitate. This pH 5 fraction was treated ac­
cording to the method of Takanami (44) to obtain transfer RNA.
RNA Determination 
The Orcinol method of Ceriotti (45) was used to determine the 
amount of RNA present in the final solution.
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DNA Determination 
The amount of DNA was determined by means of the diphenylamine 
procedure of Burton (46).
Administration of Retinoic Acid to the Rat 
Retinoic acid was administered to the animals either intraperi­
toneally or intravenously via the jugular vein as potassium retinoate. 
Injections were 0.5 ml per rat regardless of the amount of potassium 
retinoate given.
Sucrose Gradient Resolution 
The RNA solutions were purified several times before sedimenta­
tion on a linear sucrose density gradient. Sucrose solutions were made 
up in 0.01 M sodium acetate buffer, pH 5.1, containing 0.1 M sodium chlo­
ride. Gradients were prepared by means of a mixer according to the method 
of McConkey (47). The tubes were kept at 0 to 4 C for 4 to 5 hours be­
fore use to enable a limited amount of diffusion between layers to take 
place. RNA was dissolved in the sodium acetate buffer, pH 5.1, and any 
insoluble materials were removed by centrifugation. 0.3 to 0.8 ml of RNA 
solution (containing 0.5 to 1.0 mg RNA/ml) was layered on top of a 5 to 
20% linear sucrose density gradient and centrifuged in a Spinco SW-25.1 
swinging bucket rotor at 22,500 rpm for 22 hours, or at 25,000 rpm for 
17 hours. At the end of the run the rotor was allowed to slow down and 
come to a stop without the use of the brake. Following centrifugation, 
the fractions were collected continuously by means of a siphon, the tip 
of which reached to the bottom of the centrifuge tube. This siphon was 
connected to a flow-through cell of a Gilford spectrophotometer to meas­
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ure the absorbance of the fractions at 260 m|i. Each fraction (l ml) was 
collected in a tube after the measurement of the absorbance and then 
mixed in 15 ml of the scintillation liquid for the counting of radioac­
tivity.
Ribonuclease Digestion 
Some RNA samples were treated with ribonuclease prior to sucrose 
density gradient centrifugation. This ribonuclease treatment consisted 
of incubating 1.0 ml of a solution of RNA in sodium acetate buffer, pH 




In order to determine the effect of vitamin A on RNA synthesis 
and metabolism, initial experiments were undertaken to study the effect 
of vitamin A on the incorporation of labeled uridine into total liver 
RNA. Table 1 shows the results of the first experiment in which labeled 
uridine was administered to vitamin A-deficient rats and to deficient 
rats treated with 10 mg (approximately 30,000 International Units of vi­
tamin A activity) of potassium retinoate. From this table it can be seen 
that deficient rats given potassium retinoate 22 hours before killing in­
corporated considerably more uridine than did deficient rats not given 
potassium retinoate.
Figure 1 shows the effects of potassium retinoate given by in- 
traperitoneal injection to deficient rats. The data indicate a marked 
increase in incorporation of uridine into total liver RNA up to 30 hours 
after administration of 10 mg potassium retinoate.
In rate studies of uridine incorporation into normal rats (Fig­
ure 2) it appears that the peak incorporation occurs about 1 hour after 
intraperitoneal injection of labeled uridine. However, an increase in 
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TIME FROM 3H-URIDINE INJECTION TO SACRIFICE
Figure 1. Effect of time from ^H-uridine injection to sacrifice 
on rate of incorporation of ^H-uridine into total liver RNA of vitamin A 
deficient rats.
One hundred microcuries of "’H-uridine were injected intraperito­
neal ly per rat at 0 time. Four rat livers were pooled to obtain each 
point.
L i t Ten milligrams of potassium retinoate were injected in- 
traperitoneally into each rat 1.5 hours before the uridine injection.
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TIME FROM '^H-URIDINE INJECTION TO SACRIFICE
Figure 2. Effect of time from %-uridine injection to sacrifice 
on rate of incorporation of ^H-uridine into total RNA of normal rat liv­
er.
One hundred microcuries of ^H-uridine were injected intraperi­
toneal ly into each rat at 0 time. Four rat livers were pooled to obtain 
each point.
Radioactivity (DPM) per mg RNA.
Radioactivity (DPM) per 0.1 ml of liver homogenate after 
the livers were homogenized in 0.32 M sucrose solution (l part liver, 3 
parts homogenizing medium).
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radioactivity has almost disappeared from the liver. The peak in RNA 
specific activity for deficient rats is also about 1 hour (Figure 3); 
however, the extent of incorporation is much less, at all times after 
uridine injection, than in the case of the normal animals. The disap­
pearance of radioactivity from the deficient liver following %-uridine 
injection, was faster than in case of normal liver.
Having obtained these results with deficient rats, vitamin A- 
normal rats were studied. It can be seen from Figure 4 that the rate of 
incorporation of labeled uridine into the total RNA of normal rat liver 
was also stimulated by the intraperitoneal injection of this large dose 
(lO mg) of potassium retinoate. On the other hand when lower dose (l75 
ng) of potassium retinoate was given by intraperitoneal injection into 
normal rats, this lower dose of potassium retinoate did not stimulate the 
rate of incorporation of labeled uridine into total RNA.
In the experiment reported in Figure 5 potassium retinoate was 
given by intraperitoneal injection to vitamin A-deficient animals that 
were then killed at various time intervals. Labeled uridine was admin­
istered by intraperitoneal injection 1.5 hours prior to killing in each 
case. As can be seen from the figure, maximum stimulation of incorpora­
tion of uridine into RNA had already occurred at 3.5 hours after potas­
sium retinoate injection.
As a control experiment 10 mg of KCl was given by intra­
peritoneal injection to vitamin A-deficient rats. Labeled uridine was 
also intraperitoneally injected 1.5 hours before killing. The rats were 
killed at various time intervals following the KCl injection. As can be 
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TIME FROM %-URIDINE INJECTION TO SACRIFICE
Figure 3. Effect of time from %-uridine injection to sacrifice 
on rate of incorporation of %-uridine into total RNA of deficient rat 
liver.
One hundred microcuries of %-uridine were injected intraperi­
toneally into each rat at 0 time. Four rat livers were pooled to obtain 
each point.
Radioactivity (DPM) per mg RNA.
-# Radioactivity (DPM) per 0.1 ml of liver homogenate after








TIME FROM POTASSIUM RETINOATE INJECTION TO %-URIDINE INJECTION
Figure 4. Effect of potassium retinoate injection on rate of 
incorporation of ^H-uridine into total RNA of normal rat liver.
Ten microcuries of ^H-uridine were injected intraperitoneally 
into each rat 1 hour before killing.
#' # Ten milligrams of potassium retinoate were given by in­
traperitoneal injection at 0 time. Two rat livers were pooled to obtain 
each pp i nt.
0—  0 One hundred and seventy-five micrograms of potassium
retinoate were given by intraperitoneal injection at 0 time. Four rat 
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TIME FROM POTASSIUM RETINOATE INJECTION TO SACRIFICE
Figure 5. Effect of time from potassium retinoate injection on ^H-uridine incorporation into 
total liver RNA.
Ten microcuries of %-uridine were given by intraperitoneal injection 1.5 hours before kill­
ing. Each point represents four rats.
time.
#-' # Ten milligrams of potassium retinoate were given by intraperitoneal injection at 0
Ten milligrams of potassium chloride were given by intraperitoneal injection at 0 time.
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labeled uridine into total liver RNA.
Although the cortisone administration experiment which will )ae 
described later in this chapter, was not designed as a control experi­
ment, the results (shown in Figure 11) are useful as another control of 
above experiment (Figure 5).
Nuclear RNA
Following these experiments with total liver RNA, experiments 
were carried out with nuclear RNA fraction extracted from isolated rat 
liver nuclei at 65*C by 80^ phenol. Potassium retinoate (0.35 mg) was 
given by intraperitoneal injection and animals were killed at varying 
time intervals thereafter. Labeled uridine was again given 1.5 hours 
before killing. Maximum incorporation into nuclear RNA was found to oc­
cur by 4 hours after potassium retinoate administration as shown in Fig­
ure 6.
A study was undertaken with regard to %-uridine incorporation 
into nuclear RNA as a function of time after intraperitoneal uridine ad­
ministration to deficient rats and to rats given 10 mg potassium retinoate 
2 hours before killing. The data given in Table 2 are similar to those 
found for total liver RNA with no vitamin A administration as shown in 
Figures 2 and 3 and indicate that 1-1.5 hours is a satisfactory time to 
use to obtain good uridine incorporation. In the absence of vitamin A, 
little effect of time after uridine injection was observed at either 1 or 
1.5 hours after uridine injection.
Since all the above experiments were carried out with ad libitum- 
fed rats an experiment was carried out using pair-fed normal, ad libitum- 









TIME FROM RETINOATE INJECTION TO SACRIFICE
Figure 6. Effect of time from potassium retinoate injection to 
sacrifice on rate of incorporation of ^H-uridine into RNA of deficient 
rats.
Potassium retinoate (0.35 mg) was given by intraperitoneal in­
jection at 0 time. Five microcuries of ^H-uridine were given by intra­
peritoneal injection 1.5 hours before killing. Each point represents 
four rats.
"# Nuclear liver RNA
Control




EFFECT OF TIME, ON RATE OF ^h-URIDINE INCORPORATION INTO LIVER 
NUCLEAR RNA FOLLOWING POTASSIUM RETINOATE (lO mg) 












2 2 hr 0.5 hr 7.2 X 10^
2 0 hr 0.5 hr 4.9 X 10%
4 2 hr 1 hr 16.5 X 10^
4 0 hr 1 hr 5.2 X 10%
2 2 hr 1.5 hr 12.3 X 10^
3 0 hr 1.5 hr 6.6 X 10^
jection.
®Ten milligrams potassium retinoate given by intraperitoneal in- 
^Five microcuries %-uridine given by intraperitoneal injection.
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of regulating the food-intake of the normal animal by equating it with 
the amount of food eaten by the deficient animal. The goal was to elim­
inate variations in food-intake and inanition as factors in comparing vi­
tamin A-deficient animals with normal animals. At daily intervals the 
quantity of food eaten by a deficient animal is measured and that amount 
of food is given to its normal pair-mate. In the beginning each animal 
is given an equal quantity of food. The data are given in Table 3. As 
can be seen from the data graphically presented in Figure 7, pair-feeding 
did not eliminate the effect of vitamin A status on uridine incorporation 
into rat liver nuclear RNA in the vitamin A-deficient pair-fed animals.
In this experiment, the labeled uridine was given 1 hour before killing, 
and the results appear to indicate that the effect of the deficiency on 
uridine incorporation into liver nuclear RNA is more closely related to 
vitamin A status than to inanition.
A comparison of rates of incorporation of tritiated uridine into 
various liver RNA fractions of vitamin A-deficient rats, was carried out 
in order to be able to correlate the earlier total RNA data with the 
later nuclear RNA data. The results given in Table 4 show that while 
there are effects of the deficiency on all three fractions, the greatest 
effect was on the nuclear RNA fraction.
Since a nuclear RNA response to 0.35 mg of potassium retinoate 
was obtained, experiments were next undertaken using lower levels of po­
tassium retinoate. Figure 8 reports the results for 1 hour uridine in­
corporation found at 3.5 hours after various levels of potassium reti­
noate, from 3 to 350 p,g. In this experiment, times of 3.5 hours after 
potassium retinoate and 1 hour after %-uridine were arbitrarily chosen.
29
TABLE 3
COMPARISON OF ^h-URIDINE INCORPORATION INTO LIVER NUCLEAR RNA 
IN VITAMIN A-DEFICIENT RATS, THEIR PAIR-FED CONTROLS,








Normal pair-fed 5 9,610
Normal ad libitum-fed 6 12,720
Five microcuries %-uridine given by intraperitoneal injection 























Figure 7. Comparison of rate of incorporation of %-uridine in­
to liver nuclear RNA of deficient rats (-A), pair-fed normal rats (+A), 
and ^  libtum normal rats.
Five microcuries of %-uridine were given by intraperitoneal in­
jection 1 hour before killing.
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TABLE 4
COMPARISON OF INCORPORATION OF ^H-URIDINE INTO VARIOUS 
LIVER RNA FRACTIONS OF VITAMIN A-DEFICIENT 











Nuclear 2 3,500 7,300
2 2,900 6,700
Cytoplasmic 2 12,400 15,000
2 13,900 14,000
Total 2 10,100 14,800
2 11,300 18,700
















mg OF POTASSIUM RETINOATE INJECTED
Figure 8. Effect of amount of potassium retinoate on rate of 
incorporation of %-uridine into liver nuclear RNA of deficient rats.
Five microcuries of %-uridine were given by intraperitoneal in­
jection 1 hour before killing. Potassium retinoate was given intraperi­
toneally 3.5 hours before killing each case. Each point represents 5 to 
6 rats.
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shows at this 3.5 hour time interval a response to levels at least as low 
as 175 pg;.however, no significant response was observed at 35 pg.
The data in Figure 8 were all taken at 3.5 hours after adminis­
tration of vitamin A. It would be quite possible that a significantly 
longer time for an effect on liver nuclear RNA labeling would be required 
for an adequate amount of retinoate to reach the liver when such low lev­
els are given intraperitoneally. This would vary with the amount injected 
intraperitoneally. Therefore, an experiment was undertaken to determine 
whether a much lower level of potassium retinoate, in this case 17 pg, 
would affect liver nuclear RNA labeling in deficient rats at any subse­
quent time.
Seventeen micrograms of potassium retinoate was administered by 
intraperitoneal injection and the animals were killed at various times 
thereafter and, as before, 1 hour after uridine administration. The data 
presented in Figure 9 show clearly a response in RNA labeling; however, 
at this low level of vitamin A administration the response is much slower, 
reaching maximum at about 16 hours instead of 4 hours. Presumably this 
is due to the time required to allow retinoic acid to be transported from 
the intraperitoneal injection site to the liver in adequate quantities to 
bring about this increased incorporation. Possibly with a very much 
lower amount administered it will take longer to build up liver levels, 
whereas very high levels administered will rapidly yield a high content 
in the liver.
Cortisone Administration
Because of earlier work on the effect of vitamin A deficiency 













TIME AFTER POTASSIUM RETINOATE INJECTION TO SACRIFICE
Figure 9. Effect of time after 17 p.g potassium retinoate on 
rate of incorporation of ^H-uridine into liver nuclear RNA of deficient 
rat.
Five microcuries of %-uridine were given by intraperitoneal in­
jection 1 hour before killing. Potassium retinoate (l7 jig) was given by 
intraperitoneal injection at 0 time. Six rats were used per point.
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chemical adrenalectomy" due to the deficiency was suggested, an experi­
ment was next undertaken to study the effect of cortisone administration 
to vitamin A-deficient rats on rat liver nuclear RNA synthesis. The % -  
uridine was given 1 hour prior to killing and animals were killed at 
time intervals of 1 to 5 hours after being given 5 mg hydrocortisone.
As can be seen from Figure 10, hydrocortisone administration had no effect 
on uridine incorporation into liver nuclear RNA in these vitamin A-defi­
cient rats.
Rapidly Labeled Nuclear RNA 
Since the primary effect of vitamin A deficiency on RNA synthe­
sis appeared to be in a nuclear fraction, which according to Lang and 
Sekeris (40) is high in messenger RNA activity, experiments were carried 
out to see whether rapidly labeled nuclear RNA was particularly affected 
by vitamin A. For these studies, %-uridine was given by intravenous in­
jection and the animals were killed 5 minutes later. The nuclear RNA 
was isolated as before. The data charted in Figure 11 show a four-fold 
difference in specific activity of this rapidly labeled nuclear RNA be­
tween vitamin A-normal and vitamin A-deficient animals. This difference 
can be visualized by expressing the RNA data in terms of disintegrations 
per minute per gram of liver (two-fold difference) or per milligram of 
RNA per gram of liver (two-fold difference).
Intestinal Mucosal RNA 
Since intestinal mucosa is particularly sensitive to vitamin A 
deficiency, experiments were undertaken to study the effect of vitamin A 
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TIME AFTER CORTISONE INJECTION TO SACRIFICE
Figure 10. Effect of cortisone on rate of incorporation of % -  
uridine into liver nuclear RNA of deficient rat.
Five microcuries of 3R-uridine were given by intraperitoneal in­
jection 1 hour before killing. Five milligrams of hydrocortisone acetate 
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(POOLED LIVER) (POOLED LIVER)
Figure 11. Comparison in amount of incorporation of %-uridine 
into rapidly labeled liver nuclear RNA of vitamin A-deficient and normal 
rats.-
Five microcuries of %-uridine were given in 0.5 ml saline by
tail vein. Rats were killed 5 minutes after tail vein injection.
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RNA. Normal and deficient rats were given 5 |iCi labeled uridine by in­
traperitoneal injection and animals were killed at various time intervals 
thereafter. Intestinal mucosal nuclear RNA was isolated and its radio­
activity determined. As can be seen from Figure 12 there was at least a 
threefold difference in incorporation of labeled uridine into intestinal 
mucosal nuclear RNA between vitamin A-normal and vitamin A-deficient ani­
mals. Maximum incorporation appeared to occur about 0.5 hours after ad­
ministration of labeled uridine for normal rats and 1 hour for deficient 
rats.
Having found an effect of vitamin A status on intestinal mucosal 
RNA synthesis and an effect on rapidly labeled liver nuclear RNA, experi­
ments were undertaken in which rapidly labeled intestinal mucosal as well 
as liver RNA were studied concurrently. Vitamin A-deficient animals were 
treated with 0.175 mg potassium retinoate given by jugular vein injection. 
The animals were killed at various time intervals from 15 minutes to 15 
hours after the potassium retinoate injections. The ^H-uridine was also 
administered via the jugular vein 5 minutes before the animals were kill­
ed, following which both liver and intestinal mucosal nuclear RNA were 
isolated and counted. As can be seen from the data in Figure 13, the 
maximum response to potassium retinoate in both liver and mucosal rapidly 
labeled nuclear RNA occurred within the first 0.5 hour after administra­
tion of the vitamin.
This experiment was followed by a similar experiment in which 
35 |ig of potassium retinoate was given and the first time period was only 
15 minutes. The vitamin was given by jugular vein injection and again 5 
minutes before killing. Groups of rats were killed at various time in-












TIME FROM POTASSIUM RETINOATE INJECTION TO SACRIFICE
Figure 13. Effect of potassium retinoate on rate of incorpora­
tion of ^H-uridine into rapidly labeled nuclear RNA of vitamin A-defi­
cient rats.
Potassium retinoate (l75 p,g) was given directly into jugular 
vein at 0 time. Five microcuries of tritiated uridine were given direct­
ly into the same jugular vein 5 minutes before killing each animal. Data 
on intestinal mucosal RNA represent four rats per point. Data on liver 




tervals from 15 minutes to 14 hours after the single potassium retinoate 
injection. A control series of vitamin A-deficient rats were injected 
with 35 pg of KCl at zero time. As can be seen from Figure 14, the max­
imum labeling of the rapidly labeled RNA from the intestinal mucosa had 
occurred within 15 minutes after vitamin A administration. However, with 
this low "physiological level" of vitamin A there is a second slow in­
crease in labeling from 4 to 14 hours. The liver RNA data are similar 
to the intestinal mucosal RNA data except that with this low vitamin A 
dose the initial peak in labeling is less pronounced and lower than in 
the previous experiment with a higher dose of vitamin A.
Sucrose Gradient Resolution 
As mentioned above, the intravenous administration of potassium 
retinoate to vitamin A-deficient rats increased intestinal mucosal and 
liver nuclear RNA labeling. Based on the finding that liver nuclear RNA 
labeled in 5 minutes with %-uridine was increased in labeling within 30 
minutes after administration of 175 pg of potassium retinoate, the rapidly 
labeled liver nuclear RNA was fractionated on a 5 to 20% linear sucrose 
density gradient in order to investigate what portion(s) of the rapidly 
labeled nuclear RNA of vitamin A-deficient rat liver is stimulated by ad­
ministration of potassium retinoate.
Total Liver RNA
Initially, the total RNA of normal rat liver and of vitamin A- 
deficient rat liver were fractionated on a linear sucrose gradient. The 
sedimentation profile indicated by solid lines and the radioactivity pat­









TIME AFTER POTASSIUM RETINOATE INJECTION TO SACRIFICE
Figure 14. Effect of potassium retinoate on rate of incorpora­
tion of ^H-uridine into rapidly labeled RNA of vitamin A-deficient rats.
( ") Potassium retinoate (35 pg) was given directly into a
jugular vein at 0 time. Five microcuries of %-uridine were given di­
rectly into the same vein 5 minutes before killing each animal. Data on 
the treated groups represent four rats per point. (•) Liver. (X) In­
testinal mucosa.
(---- ) Thirty micrograms of KCl were given by intrajugular
vein injection at 0 time to the control rats. Data on the control groups 





















Figure 15. Sedimentation profiles of total RNA.










tion profile is an absorbance curve at 260 m|i, the peaks of which indicate 
the fractions of the RNA solution fractionated. The sedimentation coef­
ficients were taken from the data obtained by Roberts and Newman (48).
The first fraction was taken from the bottom and the last fraction was 
taken from the top of the centrifuge tube. The peak of the radioactivity 
(counts per minute) indicates the rapidly labeled RNA fraction. As can 
be seen from Figure 15, rapidly labeled total RNA is mainly incorporated 
in fractions smaller than 28 S in both normal and deficient livers. How­
ever, the rate of incorporation into normal total RNA was much higher 
than into deficient total RNA. It has been found that the separation of 
28 S from 18 S was poor in the sedimentation profile of vitamin A-defi­
cient total RNA compared with that obtained using normal total RNA. This 
problem will be discussed in Chapter IV.
Nuclear Liver RNA
Figure 16 shows the comparison of the sedimentation profiles of 
nuclear RNA of normal rat liver with that of deficient rat liver. The 
sedimentation profile of normal nuclear RNA shown at the top of Figure 16 
is similar to that of normal total RNA shown at the top of Figure 15, but 
a little different from that of deficient nuclear RNA shown at the bottom 
of Figure 16. In the sedimentation profile of vitamin A-deficient rat 
liver nuclear RNA, the height of the 28 S peak is much lower and almost 
the same as that of 18 S peak. The separation of 28 S from 18 S was 
slightly poorer than in case of liver nuclear RNA of vitamin A normal 
rats.
The rapidly labeled nuclear RNA of normal rat liver shown by the 





























Figure 16. Sedimentation profiles of nuclear RNA.
The details are given in the text. ( ) Absorbance. (•
Radioactivity.
46
peak is just below the 18 S region and the smaller is near the 4 S re­
gion. The rapidly labeled nuclear RNA of deficient rat liver shown at 
the bottom of the figure is also found in apparently the same two frac­
tions, but the amount of radioactivity incorporated in these peaks is 
much lower than in the case of the normal rat liver nuclear RNA. The re­
sults of both the overall sedimentation profiles and the uridine incor­
poration patterns indicate that vitamin A deficiency lowers the ability 
of synthesis of rapidly labeled nuclear RNA. If this is true, the admin­
istration of vitamin A to vitamin A-deficient rat must influence the syn­
thesis of the rapidly labeled nuclear RNA of vitamin A-deficient rat.
In order to examine the effect of potassium retinoate adminis­
tration on the synthesis of rapidly labeled nuclear RNA, 175 |ig of potas­
sium retinoate were given intravenously at various times before killing 
and 5 p,Ci of labeled uridine were given always 5 minutes before killing. 
Control experiments were carried out with the intravenous injection of 
175 jxg of potassium chloride to the animals 0, 20 or 40 minutes before 
killing. These three profiles at 0, 20 and 40 minutes were almost iden­
tical and are shown at the right hand bottom of Figure 17.
As can be seen from Figure 17, at 0 time treated with potassium 
retinoate, there were no significant absorbance peaks of RNA larger than 
28 S. This seems to be characteristic of vitamin A deficiency (cf. Fig­
ure 16). However, approximately 20 minutes after the retinoate treat­
ment, the 45 S species appeared and then the second peak, 35 S, appeared. 
By 90 minutes the sedimentation profile appears to be quite normal (cf. 
Figure 16).
Rapidly labeled nuclear RNA, indicated by the broken lines, ap-
47
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Figure 17. Sedimentation profiles of nuclear RNA of vitamin 
A-deficient rat liver treated with potassium retinoate.
The details are given in the text. (* 
Radioactivity.
• ) Absorbance. (-----)
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peared in the same species at 0 time as in normal nuclear RNA, i.e., be­
low 18 S and near 4 S regions. However, the rate of incorporation of 
tritiated uridine into the RNA was much less than previously found in 
normal nuclear RNA and similar to that observed in deficient nuclear RNA 
(shown in Figure 16). However, potassium retinoate administration pro­
gressively charged this labeling pattern with time after potassium reti­
noate administration. This increase stimulating first the peak just be­
low 18 S, reached a maximum by 20 minutes after potassium retinoate 
treatment, and then started to decrease gradually. As the labeling of 
this peak decreases the radioactivity in the 45 S and 4 S peaks increased. 
At 50 minutes the radioactivity of the 35 S peak was markedly increased. 
By 90 minutes the tritiated uridine incorporation pattern is close to 
that of the normal nuclear fraction shown in Figure 16. These changes in 
radioactivity shown by the broke., lines are shown from the 0 time sedi­
mentation profile to the 90 minutes sedimentation profile in Figure 17.
The patterns of the absorbance curve and the radioactivity curve 
obtained from the control experiments with KCl-treatment at 0, 20 and 40 
minutes were identical to the 0 time treatment with potassium retinoate. 
The results of this experiment show that the injection stress of potas­
sium chloride had no effect on rapidly labeled nuclear RNA synthesis in 
vitamin A-deficient rat liver.
Microsomal and Transfer Liver RNA
The next two figures (Figures 18 and 19) show the results of ex­
periments designed to determine the possibility of effects on other RNA 
fractions. Figure 18 shows the profiles of three different species of 
microsomal RNA obtained from nutritionally different animals. The top
49
































Figure 18. Sedimentation profiles of microsomal RNA.
The details are given in the text. (■—  ) Absorbance. (■
Radioactivity.
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Figure 19. Sedimentation profiles of transfer RNA isolated 
from pH 5 fraction.
The details are given in the text. (— ■ ■ ) Absorbance. (-■ 
Radioactivity.
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is the profile of microsomal RNA obtained from normal rat liver; the mid­
dle one is the profile of microsomal RNA from deficient rat liver; and 
the bottom is from deficient rat liver treated with potassium retinoate. 
Almost identical patterns were obtained. This indicates that, under the 
experimental conditions employed, no significant amount of the radioac­
tive uridine was incorporated into microsomal RNA, and potassium reti­
noate had no effect on the synthesis of microsomal RNA.
Figure 19 shows the profiles of transfer RNA isolated from the 
pH 5 fraction of vitamin A-deficient rat liver and of deficient rat liver 
treated with potassium retinoate 15 minutes before killing. Potassium 
reinoate showed no effect on transfer RNA synthesis in vitamin A-deficient 
rat liver.
Ribonuclease Digestion 
Some of the nuclear RNA, microsomal RNA and transfer RNA solu­
tions were digested by pancreatic ribonuclease prior to sedimentation.
The samples treated with the enzyme were then subjected to ultracentrifu­
gation under the same conditions described above. There were no peaks at 
260 mp; and the radioactivity was found at the top of the centrifuge tube. 




From the data presented it seems clear that in some way vitamin 
A given as potassium retinoate rapidly increases the incorporation of 
labeled uridine into intestinal mucosal and liver nuclear RNA. This 
"turn on" of nuclear RNA synthesis by vitamin A occurs following the ad­
ministration of physiological (35 [j.g) doses of potassium retinoate as 
well as after very high (10 mg) doses. With the lowest levels of potas­
sium retinoate administration the first response appears to be much 
greater for intestinal mucosa than for liver nuclear RNA.
Injection Route of Potassium Retinoate
The time required for the "turn on" of nuclear RNA synthesis 
following vitamin A administration depends on the route of administra­
tion. Thus, the peak in stimulation of uridine incorporation appears at 
3 to 4 hours following intraperitoneal injection of potassium retinoate 
and within 15 minutes when vitamin A is given intravenously.
When uridine incorporation into nuclear RNA is examined 1 or 1.5 
hours after uridine administration the peak effect of potassium retinoate 
treatment of vitamin A deficient animals by intraperitoneal injection ap­
pears at about 4 hours after giving the vitamin. However, when very
52
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rapidly labeled nuclear RNA is studied in animals killed 5 minutes after 
intravenous injection of uridine, the peak effect of potassium retinoate 
is found to occur very rapidly (within 20 minutes).
Potassium Retinoate Versus Retinol 
A significant difference is noted in the response of RNA synthe­
sis when injection of potassium retinoate versus injection of retinol are 
compared under the same experimental conditions (49). In the case of po­
tassium retinoate a maximum response occurs at approximately 30 minutes. 
However, retinol injection causes a very slow increase up to 70 hours; 
no peaks appear. Thus, potassium retinoate is the more efficient form 
of vitamin A for the study of RNA synthesis.
Incorporation Rates of Normal and 
Deficient Animals
When normal and deficient animals are compared with regard to 
uridine incorporation into rapidly labeled RNA, a threefold difference is 
found. Also, an increased rate of synthesis is indicated, since the peak 
incorporation is reached at or before 30 minutes for the normal as com­
pared to 1 hour in the deficient animals.
Vitamin A-DNA Relationship 
The effect of potassium retinoate on the rate of incorporation 
of tritiated thymidine into DNA of vitamin A deficient rats has been ex­
amined (49). There is no significant effect on DNA synthesis up to 70 
hours after the thymidine administration. The rate of incorporation be­
gins to increase slowly in the retinoate treated rats after 70 hours.
This increase may be due to the secondary effect of retinoate treatment.
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Although vitamin A has no direct effect on DNA synthesis, vitamin A might 
have direct effects on transcribability of chromatin suggested by the re­
port that chloroquine which has a structure vaguely analogous to vitamin 
A, forms a complex with DNA (50), and by the report that dormin (abscis- 
in), another possible vitamin A analog, exerts its leaf shedding effect 
by virtue of complexing with DNA and thus "shutting off" transcription 
(51, 52). Supporting the transcription site for vitamin A action is the 
observation by Raisz (53) that actinomycin D blocks the induction of 
bone resorption by vitamin A. The finding of De Luca et al̂ . (lO) that 
certain aminoacyl-t-RNA synthetases of the intestinal mucosa are decreased 
by vitamin A deficiency may be the mechanism whereby the effect of vita­
min A on transcription is exerted on protein synthesis.
The effect of high levels of vitamin A on the production of al­
most 1009̂  incidence of birth defects could be well explainable on the 
basis of an effect of vitamin A on DNA transcription (54, 55, 56).
Hormonal Effect on Rapidly Labeled 
Nuclear RNA Synthesis
Tata (57) and Tata and Williams-Ashman (58) have shown cell mem­
brane changes brought about by various hormones. However, in these cases, 
the increase in RNA synthesis reached a maximum in about 24 hours (59).
On the other hand, stimulation of rapidly labeled nuclear RNA in the 
uterus by estradiol-17 p is one of the earliest (2 to 20 minutes) re­
sponses of that organ (60, 61, 62), and they concluded (63) that estrogen 
regulates the rate and amount of genetic translation in the uterine cyto­
plasm by differentially controlling genetic transcription. An interest­
ing observation has been reported (64) that cyclic-3',5'-adenylic acid
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stimulates uridine incorporation in the uterus, taken from the ovariec- 
tomized rat and incubated for 1 hour in the presence of the nucleotide.
It has also been reported that the generation of cyclic AMP occurs 15 
seconds after the rat uterus is stimulated by estrogen (65), although 
its significance is yet uncertain in this case. Interestingly, vitamin 
A-deficient female rats do not respond to estrogen (66), indicating that 
the site of action of vitamin A may be metabolically before the site of 
action of estrogen.
Sucrose Density Resolution
The results from sucrose density analysis of the RNA samples 
isolated as described above, show that administration of potassium reti­
noate to vitamin A-deficient rats quickly stimulates the synthesis of a 
particular portion of rapidly labeled nuclear RNA. but does not signifi­
cantly stimulate the synthesis of rapidly labeled microsomal and transfer 
RNA. As can be seen from Figure 17, potassium retinoate stimulated the 
synthesis of a particular portion of rapidly labeled nuclear RNA of vita­
min A-deficient rat liver (shown by the broken lines) which was found 
just below 18 S region within 20 minutes. However, incorporation into 
this peak stimulated by potassium retinoate administration decreased 30 
minutes after potassium retinoate administration, along with an increase 
in incorporation into the 45 S and 4 S peaks. At 50 minutes increases 
in incorporation into all heavier RNA fractions were found as well.
The sedimentation profile (shown by a solid line) and radioac­
tivity curve (shown by a broken line) of nuclear RNA of vitamin A-defi­
cient rat liver treated with potassium retinoate 90 minutes before kill­
ing (also shown in Figure 17) are almost identical to that of nuclear
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RNA of normal rat liver. Although it takes more than a week to cure the 
symptoms of vitamin A deficiency of vitamin A-deficient rat after giving 
potassium retinoate, potassium retinoate administration to vitamin A-de­
ficient rat quickly affects the RNA synthesis at the molecular level.
It seems that a particular portion of rapidly labeled nuclear 
RNA (below 18 S) is the precursor(s) of some other RNA fraction. Drews 
and Brawerman (67) reported that in rapidly labeled RNA from rat liver, 
the largest amount of template activity was found in the 9-16 S sedimen­
tation zone. Rousseau and Crabbe (68) also found that rapidly labeled 
RNA in toad bladder was located in portions smaller than 18 S but larger 
than 4-6 S. Morimoto et (69) also reported that rapidly labeled nu­
clear RNA from calf thymus was found in the 9 S region.
Since, when 175 pg of potassium retinoate is intravenously given 
to a normal rat 15 minutes before killing, no appreciable change in both 
the sedimentation patterns and the rate of incorporation of tritiated 
uridine into rapidly labeled liver nuclear RNA has been observed compared 
with the case without any retinoate treatment, the retinoate effectively 
stimulates the synthesis of rapidly labeled nuclear RNA of vitamin A-de­
ficient rats under the conditions employed. However, if potassium reti­
noate is given to normal rats long enough before killing it also stimu­
lates RNA synthesis (shown in Figure 4).
Another interesting finding in this sucrose density analysis is 
a characteristic sedimentation pattern of vitamin A-deficient RNA. One 
of the serious technical difficulties involved in obtaining the sedimen­
tation profile of vitamin A-deficient RNA was poor separation of peaks of 
the 18 S to 28 S fractions. Several possible combinations of time and
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speed of the ultracentrifugation, density range of the sucrose solution, 
and the buffer for the sucrose solution, have been examined to obtain 
better separation of the 18 S to 28 S peaks. However, all attempts were 
unsuccessful in deficient RNA while reasonable separation of the normal 
RNA profile and of the deficient RNA profile treated with potassium reti­
noate before killing, were obtained. This poor separation of the 18 S 
to 28 S fractions appears to be a characteristic of the vitamin A-defi­
cient RNA profile. Vitamin A may be involved, somehow, in differentia­
tion of 18 S and 28 S RNA in the cells, i.e., in packaging or processing 
of nuclear RNA.
From the data obtained from this investigation, it is difficult 
to conclude the exact functional site of vitamin A in the animal body. 
However, it demonstrates that the administration of retinoic acid stim­
ulates the synthesis of a specific rapidly labeled liver nuclear RNA 
(below 18 S) within 10 to 20 minutes. Furthermore, this rapidly labeled 
nuclear RNA (below 18 S) could act as a precursor of the 45 S RNA frac­
tion, which may be responsible for the synthesis of a certain particu­
lar protein, the lack of which would cause the symptoms of vitamin A de­
ficiency in the animal body.
There is an alternative hypothesis based on an observation that 
the synthesis of the 4 S fraction is increased, following the decrease 
of the rapidly labeled RNA fraction (below 18 S). This hypothesis is 
that the rapidly labeled nuclear RNA fraction (below 18 S) may be a pre­
cursor of 4 S fraction and be dissociated to the 4 S fraction at a later 
time.
Another possibility is that the rapidly labeled RNA fraction
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(below 18 s) is a precursor of both 45 S and 4 S fractions.
All of these three possible ways to interpret the data obtained 
from this investigation will be studied in the future. The effect of 
vitamin A deficiency and vitamin A therapy on pool sizes and turn-over 
rates of uridine, uridine phosphates and RNA must be investigated al­
though the apparent specificity of the vitamin A effect argues against 
a "dilution by pool" explanation.
Another problem arising from the data obtained in this investi­
gation is the possibility of a toxic effect of vitamin A on RNA synthe­
sis. It has been reported that when a large dose (2-5 x 10^ Interna­
tional Units) of vitamin A or its palmitate was given by mouth to rab­
bits it stimulated labeled amino acids incorporation into the plasma 
protein due to the toxic effect (70). However, when the total amount of 
vitamin A palmitate administered was less than 2 x 10^ units, changes in 
acute-phase protein were usually negligible. The amount (l75 |ig = 500 
units) of potassium retinoate used in this investigation appears to be 
low to cause toxicity. It will be studied in the future.
At present, no proof can be given as to whether the observed 
effect of vitamin A administration on RNA synthesis is direct or indi­
rect, nor can light be shed at the moment on a mechanism for the effect.
CHAPTER V 
SUMMARY
(1) The administration of retinoic acid, a biologically active 
form of retinol, in the form of the potassium salt, to vitamin A defi­
cient rats stimulates the synthesis of rapidly labeled nuclear RNA in 
both intestinal mucosa and liver. The rapidly labeled nuclear RNA, in 
liver, stimulated by potassium retinoate administration within 15 min­
utes, is found below 18 S region on linear sucrose density gradient.
This particular rapidly labeled nuclear RNA fraction may be precursor of 
another RNA, possibly the 45 S RNA fraction. The administration of the 
retinoate also stimulates, directly or indirectly, the synthesis of the 
4 S rapidly labeled nuclear RNA fraction. In the former case, the ad­
ministration of the retinoate may be involved in messenger RNA synthesis 
in the nucleus; in the latter case it may be involved in transfer RNA 
synthesis. If this interpretation is correct, the administration of po­
tassium retinoate may regulate protein synthesis at the transcriptional 
level.
(2) Potassium retinoate effects RNA synthesis more markedly in 
the intestinal mucosa than in the liver, but is not effective in the 
kidney.
(3) Retinol has less effect than potassium retinoate on the
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synthesis of rapidly labeled nuclear RNA in both liver and intestinal 
mucosa.
(4) The administration of potassium retinoate does not signi­
ficantly affect DNA synthesis in either intestinal mucosa or in liver 
of normal and vitamin A-deficient rats.
(5) The possible functional routes of vitamin A are summarized 
in Figure 20.
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Vitamin A or provitamin A taken from foods
Stored as vitamin A ester
i  Retinoic acid
(l) Direct action or (2) Converted to active form(s) 
of vitamin A
(1) Direct action or (2) Stimulates nuclear membrane 
and produces certain active 
intermediate
(1) Direct action 
to DNA 
(to form DNA-Vit.A 
complex)
(2) Regulates an enzyme 
itself such as DNA- 
dependent RNA poly­
merase
(3) Directly acts 









Figure 20. Possible functional routes of vitamin A.
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